Our results showed that the genetic and epigenetic alterations in the IGF2-H19 region with elevated expression of IGF2 mRNA identified in WTs were also found in the great majority of HB tumours, although the incidences of LOH and LOI may be lower in HBs than in WTs. This evidence concerns the gene IGF2 and neoplasm.